Skip to main content
H

HLSCIENCE Co., LTD — Investor Relations & Filings

Ticker · 239610 ISIN · KR7239610009 KO Manufacturing
Open in API
Filings indexed 181 across all filing types
Latest filing 2026-04-17 Director's Dealing
Country KR South Korea
Listing KO 239610

About HLSCIENCE Co., LTD

https://hlscience.com

HLSCIENCE Co., LTD. is a bio-healthcare company that researches, develops, and manufactures health functional foods from natural raw materials. Employing master's and doctorate-level researchers, the company focuses on creating scientifically-backed products with a specialization in endocrinology and skin health. Its portfolio includes solutions for skin moisturizing, UV protection, and antioxidant care. HLSCIENCE conducts its own clinical tests to validate the safety and efficacy of its products, utilizing patented technologies to deliver differentiated and professional healthcare solutions.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled “임원ㆍ주요주주 특정증권등 소유상황보고서” submitted to the Financial Services Commission and Korea Exchange, detailing insider (director/executive) and major shareholder security holdings and transaction history. It is an insider shareholding disclosure, matching the Directors’ Dealing category.
2026-04-17 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled “정기주주총회결과” (Annual General Meeting results) and includes detailed vote outcomes for each resolution (approval rates, vote counts), director elections, dividend decisions, and related AGM items. This exactly matches the definition of a Declaration of Voting Results & Voting Rights Announcement. It is not the full AGM presentation nor a report publication notice, but the official voting results disclosure. Therefore, the correct classification is DVA.
2026-03-24 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a formal regulatory “신고” (report) to the Financial Services Commission/KRX regarding the appointment, reappointment, and mid-term resignation of outside directors (사외이사). It outlines the date of change, number of directors, pre- and post-change board composition, and details of each appointed/reappointed director. This clearly constitutes an announcement of changes to the company’s board of directors, matching the Board/Management Information category.
2026-03-24 Korean
사업보고서 (2025.12)
Annual Report Classification · 1% confidence The document is a 'Business Report' (사업보고서) for the 26th fiscal year (2025) of HL Science Co., Ltd. It contains comprehensive sections including company overview, business details, financial information, management analysis, and governance, which are characteristic of an Annual Report (10-K equivalent in the Korean regulatory context). FY 2025
2026-03-16 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report). It provides a summary of the audit opinion, financial statements (consolidated and separate), and key financial metrics for the fiscal year ending 2025-12-31. While it contains financial data, it is a standard regulatory disclosure form used in the Korean market (DART/KIND) to announce the receipt and submission of the audit report, rather than the full, multi-page annual report document itself. Therefore, it is classified as a Regulatory Filing. FY 2025
2026-03-16 Korean
임원ㆍ주요주주특정증권등거래계획보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Trading Plan for Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 거래계획보고서) filed with the Financial Supervisory Service and the Korea Exchange. This document details the planned future stock transactions of an executive (Lee Dong Hyun) of HL Science Co., Ltd. It includes the purpose of the trade, the planned quantity, price, and the timeline for the transaction. This falls under the category of director/executive dealings and planned transactions, which is best classified as 'Director's Dealing' (DIRS) within the provided schema.
2026-03-12 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.